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Abstract
Background: Lachancea fermentati is an environmental yeast that is also used in the fermentation of alcoholic
drinks. It has not previously been described as a human pathogen although the closely related yeast, Saccharomyces
boulardii, can cause fungemia. Here we report a case of L. fermentati acting as a pathogen in a septic patient with
cultures positive from blood, peritoneal fluid, bile, and sputum.
Case presentation: A 36 year-old Caucasian man was hospitalized with acute alcoholic hepatitis complicated by
Escherichia coli spontaneous bacterial peritonitis. Three days after admission, he developed new fevers with sepsis
requiring mechanical ventilation and vasopressor support. He was found to have a bowel perforation. Cultures from
blood, peritoneal fluid, and sputum grew a difficult-to-identify yeast. Micafungin was started empirically. On hospital
day 43 the yeast was identified as L. fermentati with low minimum inhibitory concentrations (by Epsilometer test) to all
antifungals tested. Micafungin was changed to fluconazole to complete a 3-month course of therapy. Serial
peritoneal fluid cultures remained positive for 31 days. One year after his initial hospitalization the patient had
ongoing cirrhosis but had recovered from fungemia.
Conclusion: This case demonstrates the need for clinicians to consider host factors when interpreting culture results
with normally non-pathogenic organisms. In this immunocompromised host L. fermentati caused disseminated disease.
We believe his hobby of brewing alcohol led to colonization with L. fermentati, which then resulted in invasive disease
when the opportunity arose.
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Background
Non-Candida fungemia has become increasingly prob-
lematic among immunocompromised hosts, and fungal
genera such as Trichosporon, Cryptococcus, Rhodotorula,
Malassezia, and Blastoschizomyces have become recog-
nized as opportunistic pathogens [1-3]. The genus Saccha-
romyces has also been described as a human pathogen [4-6].
We describe a case of fungemia and sepsis due to the yeast
Lachancea fermentati, a species closely related to the sac-
charomycetes. The known potential of Saccharomyces to act
as a pathogen suggests that the related species, L. fermentati,
may also have the ability to cause disease in the appropriate
clinical setting.
Case presentation
A 36 year-old man with acute alcoholic hepatitis was hospi-
talized due to Escherichia coli peritonitis attributed to spon-
taneous bacterial peritonitis. His social history was notable
for brewing his own alcohol and alcohol abuse. He initially
improved symptomatically, but three days after admission
he developed a fever to 38.1°C and multi-organ failure
requiring mechanical ventilation, continuous renal replace-
ment therapy, and vasopressor support. He clinically stabi-
lized with intensive critical care support and initiation of
empiric antibiotics (vancomycin, meropenem, and micafun-
gin). Blood cultures at the time of admission were negative.
One of four blood culture bottles drawn at the time of clin-
ical decompensation became positive for yeast after
12 hours of incubation (BacT Alert System®, Biomerieux,
Durham, NC). Sputum and peritoneal fluid cultures col-
lected the following day also grew the same yeast. Culture
showed creamy white colonies on Sabouroud-dextrose agar* Correspondence: leuck002@umn.edu
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(Figure 1). The yeast was not immediately identifiable by
the clinical microbiology lab.
During the two-month admission, he was found to have
loculated ascites associated with a fistulous connection to
bowel. Multiple abdominal abscess and peritoneal fluid
cultures had polymicrobial growth (Table 1). Despite the
intermittent presence of other organisms, every peritoneal
culture over a one-month period, nine in total, grew the
same difficult-to-identify yeast. This same yeast also grew
from three sputum cultures (Table 1). The yeast isolated
from sputum was felt to more likely represent colonization
than infection. The patient had pleural effusions attrib-
uted to his ascites but he did not have a clinical pneumonia.
Urine cultures remained negative. Medical management in-
cluded aggressive drainage of the abdominal fluid collections
and continuation of broad-spectrum antimicrobials includ-
ing meropenem, vancomcyin, and micafungin. Over time,
the patient slowly improved with resolution of the abdom-
inal pain, fever, leukocytosis, and abdominal abscesses.
On hospital day 43, the yeast isolated from blood, peri-
toneal fluid, bile, and sputum was identified as Lachan-
cea fermentati by the Fungus Testing Laboratory at the
University of Texas Health Science Center. Identification
was based on cornmeal agar morphology, cycloheximide
susceptibility studies, temperature studies, and sequen-
cing of the D1/D2 regions of 28 s rDNA. No susceptibil-
ity breakpoints are available for L. fermentati, but the
minimum inhibitory concentration (MIC) was low for all
antifungal agents tested (Table 2). When MIC values were
known, micafungin was changed to fluconazole 100 mg
daily (approximately 3 mg/kg, the renal-adjusted dose
equivalent of 6 mg/kg). He completed 6 weeks of ther-
apy with micafungin and an additional 6 weeks of flu-
conazole, for a total 3 months of antifungal therapy.
One year after his initial presentation he remained ab-
stinent from alcohol and fully recovered from the fun-
gemia. He does have cirrhosis and at the time of his
last clinic visit he continued on ciprofloxacin for spon-
taneous bacterial peritonitis prophylaxis.
Conclusions
L. fermentati is an environmental, saprophytic yeast found
in decaying material. In its natural setting, Lachancea
colonizes leaf surfaces and may provide a natural buffer
against plant pathogens [7]. Lachancea species, in com-
bination with Saccharomyces cerevisiae, are commonly
used in the fermentation process to make wine and ca-
chaca (a drink made from fermented sugar) [8,9], and have
been shown to enhance the quality and aroma of these
beverages [10].
While L. fermentati has been recognized as a component
of fermented drinks, it may be more pervasive than previ-
ously thought. L. fermentati was found in more than 50%
of olive oil mills tested [5], and an investigation of com-
mercially available drinks in Brazil also found L. fermentati
in coconut juice and reconstituted fruit juices [11]. A spe-
cies with a close evolutionary relationship to L. fermentati,
L. thermotolerans, is present on the leaves of deciduous
trees in the autumn when fruit would be harvested [7].
With this increasing recognition of Lachancea’s environ-
mental presence, clinicians and clinical microbiologists
should be aware of its pathogenic potential.
Recent progress has also been made in the classification
of Lachancea yeasts. L. fermentati, formerly known as
Zygosaccharomyces fermentati, is related to the genus
Saccharomyces. Prior to DNA sequencing, classification of
these organisms was based on morphologic and pheno-
typic characteristics. The advent of nuclear-based rDNA
sequencing technology, coupled with multigene-based
phylogenetic analyses, has led to reclassification of the
11 clades of Saccharomycetaceae. The genus Lachancea
consists of five species, L. cidri, L. fermentati, L. kluyveri,
L. thermotolerans and L. waltii. The organism is further
characterized by vegetative reproduction with multilateral
Figure 1 Front and back view of L. fermentati grown on Sabouroud dextrose agar showing the creamy white colonies typical of yeast.
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budding on a narrow base and fermentation of glucose in
addition to at least one other sugar [12]. Based on com-
parative analyses of rDNA sequences and molecular
karyotyping of Lachancea species, the yeast appears to
have eight chromosomes [13], and its preferred growing
temperature is 25-37°C [14]. This range includes normal
human body temperature and suggests that L. fermentati
could act as a pathogen.
Of interest, one of this patient’s early paracenteses
grew Eggerthella lenta, which is associated with the
gastrointestinal flora of wine drinkers [15]. This patient
did indeed brew his own alcohol. Taken together, the
presence of two microorganisms associated with fermen-
ted drinks suggests that his microbiome may have been
affected by his alcohol brewing and consumption, result-
ing in infection with an unusual pathogen, L. fermentati.
In a similar case, S. cerevisiae (baker’s yeast) caused dis-
seminated disease in a baker’s wife with leukemia, which
was thought to be associated with occupation-related
colonization [16].
To the best of our knowledge, this is the first case
reporting L. fermentati as a human pathogen. This case
of L. fermentati fungemia highlights the ability of non-
pathogenic microorganisms to cause disease in unusual
situations depending on host risk factors and clinical cir-
cumstances. If this patient had not been fungemic and
septic, this yeast might have been considered a coloniz-
ing species. However, in this immunocompromised host
with a perforated viscus, it acted as a pathogen and re-
quired treatment.
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